glp 1 and cancer treatment Glucagon-like peptide receptor agonists risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research GLP-1 receptor agonists in the
Description
Ruotolo G, Howard BV

Andrew has an MSci (Hons.) degree in medical and biological chemistry from the University of Nottingham, with his penultimate undergraduate year spent working with AstraZeneca in Sweden

Although originally prescribed to treat type 2 diabetes (Ozempic and Mounjaro), semaglutide and tirzepatide are becoming more and more popular for weight loss

GLP-1 medications are powerful, but they're prescription drugs with real side effects
A 2024 News Medical review notes that berberine activates the AMPK pathway, supporting metabolism, though its effects are milder than GLP-1 drugs like Ozempic

In February 2026, the FDA released a report alerting patients and providers about the risks of compounded GLP-1 medications
